Ein Business-Meeting (Symbolbild).
Montag, 18.04.2022 17:46 von | Aufrufe: 116

Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR

Ein Business-Meeting (Symbolbild). © gilaxia / E+ / Getty Images

PR Newswire

NEW YORK, April 18, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

  • Antares Pharma, Inc. (ATRS), relating to its proposed acquisition by Halozyme Therapeutics, Inc. Under the terms of the agreement, ATRS shareholders will receive $5.60 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/antares-pharma-inc. It is free and there is no cost or obligation to you.

  • Sierra Oncology, Inc. (SRRA), relating to its proposed acquisition by GlaxoSmithKline plc. Under the terms of the agreement, SRRA shareholders will receive $55.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/sierra-oncology-inc. It is free and there is no cost or obligation to you.

  • SailPoint Technologies Holdings, Inc. (SAIL), relating to its proposed acquisition by Thoma Bravo. Under the terms of the agreement, SAIL shareholders will receive $65.25 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/sailpoint-technologies-holdings-inc. It is free and there is no cost or obligation to you.

  • Datto Holding Corp. (MSP), relating to its proposed acquisition by Kaseya. Under the terms of the agreement, MSP shareholders are expected to receive $35.50 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/datto-holding-corp. It is free and there is no cost or obligation to you.
  • CDK Global, Inc. (CDK)relating to its proposed acquisition by Brookfield Business Partners LP. Under the terms of the agreement, CDK shareholders will receive $58.47 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/cdk-global-inc. It is free and there is no cost or obligation to you.

  • Vidler Water Resources, Inc. (VWTR), relating to its proposed acquisition by D.R. Horton, Inc. Under the terms of the agreement, VWTR shareholders will receive $15.75 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/vidler-water-resources-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.


ARIVA.DE Börsen-Geflüster

SOURCE Monteverde & Associates PC

Werbung

Mehr Nachrichten zur Antares Pharma Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News